
==== Front
Echo Res Pract
Echo Res Pract
Echo Research and Practice
2055-0464
BioMed Central London

39218983
56
10.1186/s44156-024-00056-x
Research
Assessment of left ventricular myocardial systolic dysfunction in premature ovarian insufficiency patients using echocardiographic layer-specific myocardial strain imaging
Wang Yu-Lin 1
Yin Li-Xue yinlixue_cardiac@163.com

1
Li Mei 2
1 Ultrasound in Cardiac Electrophysiology and Biomechanics Key Laboratory of Sichuan Province, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, 610072 China
2 Department of Gynaecology and Obstetrics, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
2 9 2024
2 9 2024
2024
11 2015 2 2024
2 7 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background

Due to the lack of oestrogen, premature ovarian insufficiency (POI) is an independent risk factor for ischaemic heart disease and overall cardiovascular disease. This study aimed to apply layer-specific myocardial strain for early quantitative evaluation of subclinical left ventricular myocardial systolic function changes in patients with POI.

Methods

Forty-eight newly diagnosed, untreated patients with POI (POI group) and fifty healthy female subjects matched for age, height and weight (control group) were enrolled. Standard transthoracic echocardiography was used to measure conventional parameters and layer-specific strain parameters.The layer-specific strain parameters included subendomyocardial global longitudinal strain (GLSendo), mid-layer myocardial global longitudinal strain (GLSmid), subepimyocardial global longitudinal strain (GLSepi), subendomyocardial global circumferential strain (GCSendo), mid-layer myocardial global circumferential strain (GCSmid), and subepimyocardial global circumferential strain (GCSepi).

Results

There were no significant differences in age, body mass index (BMI), blood pressure, or left ventricular ejection fraction (LVEF) between the two groups. The end-diastolic interventricular septal thickness (IVST) was greater in the POI group (8.29 ± 1.32 vs. 7.66 ± 0.82, P = 0.008), and the POI group had lower E, E/A, and lateral e′ (all P < 0.05). As for systolic functions,the POI group had lower GLSendo, GLSmid, GLSepi, GCSendo, GCSmid, and GCSepi (all P < 0.05).The intraobserver and interobserver coefficients of GLSendo, GLSmid, GLSepi, GCSendo, GCSmid, and GCSepi were greater than 0.900.

Conclusions

POI patients with normal LVEF may suffer from subclinical left ventricular myocardial systolic dysfunction. Echocardiography of layer-specific myocardial strain could more sensitively detect subclinical impairment of left ventricular systolic function in POI patients.

Graphical abstract

Keywords

Premature ovarian insufficiency
Layer-specific myocardial strain
Echocardiography
Left ventricle
Systolic function
issue-copyright-statement© British Society of Echocardiography 2024
==== Body
pmcIntroduction

Premature ovarian insufficiency (POI) refers to a clinical syndrome caused by the loss of ovarian activity in women before the age of 40 years and mainly manifests as menstrual abnormalities (oligomenorrhoea or amenorrhoea), increased gonadotropins such as follicle-stimulating hormone (FSH) > 25 IU/L, and decreased oestrogen [1].

The global incidence rate of POI is 3.7% [2]. POI can be caused by chromosomal abnormalities and genetic defects (sex chromosomes and autosomes), immune system diseases, infection, or environmental or iatrogenic factors, but over 50% of patients with POI still have unknown aetiologies [3].

POI can have adverse effects on multiple systems in women, including the cardiovascular system, genitourinary system, skeletal system and mental health, and harm to the cardiovascular system can reduce life expectancy and increase the risk of heart failure [1, 4]. POI can serve as an independent risk factor for ischaemic heart disease (IHD) and cardiovascular disease (CVD) [5],and the pathophysiological mechanism affecting the cardiovascular system is mainly a series of changes caused by a lack of oestrogen. Most patients with POI have no obvious precordial discomfort in the early stage, so they often ignore changes in the cardiovascular system. In 2016, the European Society of Human Reproduction and Embryology (ESHER) recommended that all women with POI be assessed for CVD risk and receive early hormone replacement therapy (HRT) to control their future CVD risk [1]. The North American Menopausal Association also recommended HRT treatment for patients with POI without contraindications [4]. Turner syndrome (TS) is a special type of POI characterized by sex chromosomal abnormalities, and CVD-related risk factors should be assessed annually [1].

Layer-specific myocardial strain measurements are based on two-dimensional speckle tracking echocardiography (2D-STE), which can quantify the myocardial strain parameters of each layer, provide more accurate myocardial deformation information, and provide more guidance for clinical precision treatment. This study intended to use layer-specific myocardial strain to quantitatively assess subclinical myocardial systolic impairment of the left ventricle in patients with POI.

Methods

Forty-eight patients who were newly diagnosed with POI from the Menopausal Gynecological Endocrinology Clinic of our hospital were included as the POI group.

All subjects with POI underwent sex hormone testing, and patients suspected of having TS underwent chromosome testing. Inclusion criteria: meeting the POI diagnostic criteria proposed by ESHER [1]: ① age < 40 years old; ② oligomenorrhoea or amenorrhoea for at least 4 months and elevated FSH > 25 IU/L on two occasions > 4 weeks apart. Exclusion criteria: ① age > 40 years old; ② prior HRT; ③ severe cardiovascular disease, including congenital cardiovascular disease, coronary heart disease, cardiomyopathy, severe arrhythmia, heart failure, pericardial disease; ④ hypertension, diabetes, blood system disease, autoimmune system disease, or history of radiotherapy or chemotherapy; and ⑤ poor image quality. Fifty healthy voluntary subjects matched for age, height and weight with the POI group were selected as the control group. These individuals had a normal menstruation history, sinus rhythm, no hypertension, no hyperlipidaemia, no diabetes, and no history of severe cardiovascular disease. This study was reviewed and approved by the hospital ethics committee, and all the subjects signed informed consent.

Blood pressure was measured by a cuff manometer for all subjects.Complete echocardiography was performed by using Vivid E9 echocardiographic diagnostic equipment (GE Healthcare) with an M5S probe (frequency: 1.4–4.6 MHz). Two-dimensional dynamic images of at least three cardiac cycles were collected from the parasternal left ventricle long-axis view, apical 4-chamber view, apical 3-chamber view, apical 2-chamber view, left ventricular mitral valve short-axis view, papillary muscle short-axis view, and apical short-axis view. Pulsed-wave Doppler (PW) was used to collect anterior blood flow spectrum of the mitral valve in the apical 4-chamber view, and tissue Doppler imaging (TDI) was subsequently used to obtain the velocity spectrum of the lateral and septal mitral annulus.

A dedicated EHCO PAC 202 workstation was used for echocardiographic image postprocessing and measurement of the end-diastolic diameter of the left ventricle (LVEDD), the end-diastolic thickness of the left ventricular posterior wall (LVPWT), and the end-diastolic interventricular septal thickness (IVST) in the parasternal left ventricular long-axis view. The following formulas were used to calculate relative wall thickness (RWT) = 2 × LVPWT/LVEDD, left ventricular mass (LVM) = 0.8 × 1.04 × [(LVEDD + IVST + LVPWT)3 − LVEDD3] + 0.6, body surface area (BSA) = 0.0061 × height (cm) + 0.0128 × weight (kg) − 0.1529, body mass index (BMI) = weight (kg)/height(m)2, and left ventricular mass index (LVMI) = LVM/BSA. Left ventricular ejection fraction (LVEF) was measured by the biplane Simpson method, the left atrial volume (LAV) was measured by the biplane Simpson method at the apical 4- and 2-chamber views, and the left ventricular volume index (LAVI) was calculated as LAV/BSA [6].

The apical 3-chamber view, apical 2-chamber view, apical 4-chamber view, left ventricular mitral valve short-axis view, left ventricular papillary muscle short-axis view, and left ventricular apical short-axis view were selected. The Q-analysis system was started, the 2D-strain was entered to manually trace the boundary of the endocardium and epicardium, the region of interest (ROI) was determined, and the software automatically tracked the movement trajectory of the myocardial spots in each layer. Finally, the subendomyocardial global longitudinal strain (GLSendo), the mid-layer myocardial global longitudinal strain (GLSmid), the subepimyocardial global longitudinal strain (GLSepi), the subendomyocardial global circumferential strain (GCSendo), the mid-layer myocardial global circumferential strain (GCSmid), and the subepimyocardial global circumferential strain (GCSepi) were obtained (Fig. 1).Fig. 1 The software automatically tracks the movement trajectory of the myocardial spots in each layer to obtain layer-specific strain parameters. A Shows a schematic diagram of the apical 4-chamber view, and B shows a schematic diagram of the left ventricular mitral valve short-axis view

The evaluation of left ventricular diastolic function was based on guidelines proposed by ASE/EACI in 2016 [7]. Using a simple random sampling method, 10 patients were randomly selected among the POI patients for intraobserver reproducibility testing, and another 10 patients were randomly selected for interobserver reproducibility testing.

SPSS 25.0 was used for statistical analysis. The data are expressed as mean ± standard deviation. The Kolmogorov–Smirnov test was used to determine the distribution type of continuous variables, and the Levene test was used to test the homogeneity of variance. If the data from both groups satisfied both the normal distribution and homogeneity of variance criteria, the two-independent-samples t test was performed; otherwise, the Mann–Whitney U test was used for two independent samples. The intraclass correlation coefficient (ICC) was used for the reproducibility test. P < 0.05 was statistically significant for all analyses.

Results

Among the forty-eight patients in the POI group, the oestrogen levels of twenty-two patients were less than 37 pmol/L (the lowest level of serum sex hormone testing equipment was 37 pmol/L), the oestrogen levels of the other twenty-six patients were 88.37 ± 48.68 pmol/L, and the FSH level of the POI group was 66.70 ± 27.89 mIU/ml. There were five patients with TS in the POI group; three of these patients had 45,X, and the chromosomes of the other two patients were 45,X/46,XX/47,XXX and 45,X/46,X,r(X). Among the POI patients, four had primary amenorrhoea, and the abnormal menstruation history of the other forty-four patients was 13.07 ± 9.33 months.

No significant difference in age, BSA, BMI, systolic blood pressure, diastolic blood pressure, or heart rate was found between the two groups (all P > 0.05) (Table 1).Table 1 Routine clinical data of the two groups

Variable	POI (n = 48)	Control (n = 50)	P value	
Age (years)	33.00 ± 6.27	31.64 ± 7.34	0.073	
BSA (m2)	1.50 ± 0.13	1.51 ± 0.10	0.741	
BMI (kg/m2)	21.15 ± 2.45	20.59 ± 2.24	0.239	
Systolic BP (mmHg)	112.44 ± 10.47	112.96 ± 9.56	0.797	
Diastolic BP (mmHg)	69.79 ± 9.46	69.54 ± 7.27	0.878	
Heart rate (bpm)	75.48 ± 9.81	73.08 ± 8.21	0.134	
BSA body surface area, BMI body mass index, BP blood pressure

The IVST in the POI group was greater than that in the control group (P = 0.008), but there were no significant differences between the two groups in LVPWT, LVEDD, RWT, LVM, or LVMI (all P > 0.05). The values of E, E/A, and lateral e′ in the POI group were lower than those in the control group (all P < 0.05), while no differences in A, septal e′, average E/e′ or LVEF were found between the two groups (P > 0.05) (Table 2).Table 2 Conventional echocardiographic parameters of the two groups

Variable	POI (n = 48)	Control (n = 50)	P value	
IVST (mm)	8.29 ± 1.32	7.66 ± 0.82	0.008	
LVPWT (mm)	7.73 ± 1.35	7.49 ± 1.04	0.468	
LVEDD (mm)	40.79 ± 3.22	41.85 ± 3.24	0.108	
RWT	0.38 ± 0.08	0.36 ± 0.06	0.130	
LVM (g)	97.30 ± 18.57	94.72 ± 17.46	0.352	
LVMI (g/m2)	64.76 ± 11.39	62.82 ± 11.54	0.233	
E (m/s)	0.83 ± 0.13	0.94 ± 0.14	0.000	
A (m/s)	0.63 ± 0.16	0.60 ± 0.15	0.378	
E/A	1.53 ± 0.57	1.67 ± 0.50	0.038	
Lateral e′ (m/s)	0.14 ± 0.02	0.15 ± 0.03	0.004	
Septal e′ (m/s)	0.12 ± 0.03	0.13 ± 0.04	0.073	
Average E/e′	6.80 ± 1.64	7.01 ± 1.86	0.782	
LAVI (mL/m2)	21.49 ± 5.84	21.13 ± 5.74	0.761	
LVEF (%)	65.56 ± 6.05	66.78 ± 5.48	0.545	
IVST end-diastolic interventricular septal thickness, LVPWT  end-diastolic thickness of left ventricular posterior wall, LVEDD end-diastolic diameter of left ventricle, RWT relative wall thickness, LVM left ventricular mass, LVMI left ventricular mass index, E early diastolic peak velocity of mitral flow, A late diastolic peak velocity of mitral flow, E/A the ratio of E to A, lateral e′ early diastolic peak velocity of mitral lateral annulus, septal e′ early diastolic peak velocity of mitral septal annulus, Average E/e′ the ratio of E to average e′, LAVI left atrial volume index, LVEF left ventricular ejection fraction

As assessed under established guidelines [7], the left ventricular diastolic function of all the subjects remained normal, but the presence of individual abnormalities in the POI group (E, E/A, lateral e′) still suggested that there were adverse changes in left ventricular diastolic function in POI patients.

GLSendo, GLSmid, GLSepi, GCSendo, GCSmid and GCSepi were all lower in the POI group (P < 0.05 or P < 0.001). The longitudinal strain and circumferential strain parameters of the two groups all showed a decreasing trend from the subendocardium to the subepicardium (Table 3) (Figs. 2, 3).Table 3 Layer-specific strains of the two groups

Variable	POI (n = 48)	Control (n = 50)	P value	
GLSendo (%)	− 23.81 ± 3.76	− 26.03 ± 3.62	0.000	
GLSmid (%)	− 20.74 ± 3.29	− 22.90 ± 3.00	0.000	
GLSepi (%)	− 18.20 ± 2.96	− 20.20 ± 2.75	0.000	
GCSendo (%)	− 25.26 ± 7.12	− 27.10 ± 6.66	0.023	
GCSmid (%)	− 15.50 ± 4.10	− 17.31 ± 4.48	0.001	
GCSepi (%)	− 9.18 ± 3.41	− 10.07 ± 3.43	0.047	
GLSendo subendomyocardial global longitudinal strain, GLSmid mid-layer myocardial global longitudinal strain, GLSepi subepimyocardial global longitudinal strain, GCSendo subendomyocardial global circumferential strain, GCSmid mid-layer myocardial global circumferential strain, GCSepi subepimyocardial global circumferential strain

Fig. 2 Comparison of global longitudinal layer-specific strains and bull's eye diagrams in peak systolic between the control group and the POI group. A Shows the GLSendo, GLSmid, GLSepi and bull's eye diagrams in the control group, and B shows the same in the POI group. Each segment in the bull's eye diagram in A was uniformly red, but some segments in B became lighter and uneven, indicating the strains of these segments decrease

Fig. 3 Comparison of longitudinal layer-specific strains and circumferential layer-specific strains between the POI group and control group. GLSendo, GLSmid, GLSepi, GCSendo, GCSmid and GCSepi were all lower in the POI group. Similarly, the longitudinal and circumferential strain parameters of the two groups all exhibited a decreasing trend from the subendocardium to the subepicardium.*P < 0.05, **P < 0.001. Standard error was the measure of sampling error

The intraobserver and interobserver coefficients of GLSendo, GLSmid, GLSepi, GCSendo, GCSmid, and GCSepi were greater than 0.900, so the layer-specific strains had acceptable reproducibility (Table 4).Table 4 Intraobserver and interobserver reproducibility of layer-specific stains

Variable	Intraobserver coefficient	95% Confidence level	Interobserver coefficient	95% Confidence level	
GLSendo (%)	0.942	0.881–0.972	0.936	0.871–0.969	
GLSmid (%)	0.941	0.880–0.971	0.929	0.858–0.966	
GLSepi (%)	0.915	0.830–0.958	0.920	0.840–0.961	
GCSendo (%)	0.957	0.912–0.979	0.941	0.881–0.971	
GCSmid (%)	0.967	0.932–0.984	0.953	0.902–0.978	
GCSepi (%)	0.957	0.908–0.979	0.938	0.872–0.970	
GLSendo subendomyocardial global longitudinal strain, GLSmid mid-layer myocardial global longitudinal strain, GLSepi subepimyocardial global longitudinal strain, GCSendo subendomyocardial global circumferential strain, GCSmid mid-layer myocardial global circumferential strain, GCSepi subepimyocardial global circumferential strain

Discussion

Due to the loss of functional ovarian follicles, women with POI constantly have low oestrogen and face infertility, perimenopausal syndrome and other problems. Patients with POI also have a higher CVD risk [8–10], and early menopause is associated with an increased risk of heart failure [11].Since most women with POI do not have chest tightness, chest pain or other CVD-related clinical symptoms in the early stage, the risk of CVD is often ignored. Serological indicators and blood pressure are often used to detect the risk of CVD in patients with POI, but echocardiography is rarely used to test the myocardial function of POI patients. Layer-specific myocardial strain can more sensitively reflect subclinical myocardial changes in the early stage of disease than LVEF can [12, 13] and has been used in many recent studies of various diseases [14–16]. Therefore, we aimed to use layer-specific myocardial strain to evaluate left ventricular myocardial systolic function in POI patients.

In this study, the POI group had a thicker IVST than the control group (P = 0.008), suggesting that patients with POI may have left ventricular remodelling. According to the criteria for left ventricular hypertrophy proposed in guidelines [6] (LVMI > 95 g/m2 in females), all subjects in this study did not meet the criteria for left ventricular hypertrophy, but fifteen patients (34.25%) in the POI group met the criteria for left ventricular concentric remodelling (RWT > 0.42, LVMI ≤ 95 g/m2), indicating the occurrence of left ventricular remodelling in patients with POI. The possible pathophysiological mechanisms include the following: Oestradiol (E2), as a fast activator of endothelial nitric oxide synthase (NOS),can stimulate the production of nitric oxide (NO), and a lack of E2 in patients with POI results in reduced NO production by vascular endothelial cells and decreased vascular elasticity and compliance,then cardiac afterload increases, which promotes left ventricular remodelling and myocardial hypertrophy [17, 18]; otherwise, a low E2 can lead to abnormalities in the renin-angiotensin system (RAS) in the heart and systemic circulation and enhance the activity of angiotensin-converting enzyme (ACE), leading to ventricular remodelling and cardiac hypertrophy [19].

Echocardiography can not only evaluate changes in left ventricular geometry but also quantitatively evaluate changes in function. According to the guideline [7], apparent decreases in left ventricular diastolic function were not detected in any of the subjects; however, the POI group had lower E, E/A, and lateral e′ (P < 0.05 or P < 0.01), indicating there are still some signs of decreased diastolic function, which is generally consistent with relevant research [20]. An animal experiment showed that the rMCP-1 and rMCP-5 mRNAs in the cardiomyocytes of ovariectomized rats, as the isoforms of chymase that form angiotensin II (Ang II), participate in the loss of normal heart function and structure caused by ovariectomy in rodents, as indicated by decreased left ventricular diastolic function (increased E/e’) and increased LVEDD [21]. Another study showed deficiency of E2 led to reduced mitochondrial function in cardiomyocytes and inhibited NOS signalling, thereby inhibiting the GPR30 pathway, which together led to a decreased left ventricular diastolic function [18].

Changes in left ventricular diastolic function are often inseparable from changes in systolic function. However, there was no obvious abnormality in LVEF (P > 0.05), but conventional LVEF often cannot reflect subclinical changes in left ventricular systolic function. This study used layer-specific myocardial strain and revealed that GLSendo, GLSmid, GLSepi, GCSendo, GCSmid, and GCSepi in the POI group were lower than those in the control group. There findings suggested that there was a reduction in left ventricular systolic function in the POI group and that layer-specific myocardial strain could more sensitively detect left ventricular systolic function impairment in patients with POI than two-dimensional LVEF. Some possible mechanisms for the decrease in layer-specific strains of the left ventricle in the POI group are as follows: An animal experiment showed that E2 enhanced cardiac systolic function by regulating the expression of cAMP-L-type Ca2+ channel (cAMP-LTCC)-related genes and promoted cardioprotection against stress through the GPR30 nongenomic acute signalling pathway [22]. In addition, there are oestrogen receptors (ERs) in the arterial wall and myocardial tissue, including ERα, ERβ, and the G protein-coupled oestrogen receptor (GPER), and E2 might directly act on cardiomyocytes to enhance myocardial systolic function [23–25].There is a certain gradient in the deformability of the normal left ventricle myocardium, and the deformation of the myocardium from the endocardium to epicardium gradually decreases [26]. This study also confirmed this decreasing trend from the endocardium to the epicardium in all subjects.

Limitations of this study: The hospital serum sex hormone test equipment had 37 pmol/L as the baseline for oestrogen, so we could not collect the E2 levels of patients whose E2 levels were lower than 37 pmol/L. The sample was fairly small. This was only a preliminary study, and a follow-up study during hormone replacement therapy (HRT) was not conducted.

In summary, POI patients with normal LVEF may have subclinical left ventricular myocardial systolic impairment. Layer-specific myocardial strain can more sensitively detect subclinical left ventricular systolic impairment in patients with POI.

Acknowledgements

Yu-lin Wang is thankful to her supervisor Li-Xue Yin for guidance. The graphic abstract was made by Figdraw.

Author contributions

Yu-lin Wang did the data collection, analysis and wrote the manuscript. Li-Xue Yin and Mei Li conceived the idea and also did a part of data analysis. All authors reviewed the manuscript.

Funding

No funding.

Availability of data and materials

The data underlying this article will be shared on reasonable request to the corresponding author.

Declarations

Ethics approval and consent to participate

The study was approved by Sichuan People’s hospital’s ethic committee (No. 265), and all the subjects signed informed consent.

Consent for publication

All the subjects signed informed consent.

Competing interests

The authors declare no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Webber L Davies M Anderson R ESHRE Guideline: management of women with premature ovarian insufficiency Human Reprod (Oxford, England) 2016 31 5 926 937 10.1093/humrep/dew027
Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reprod (Oxford, England). 2016;31(5):926–37.10.1093/humrep/dew027
2. Golezar S Ramezani Tehrani F Khazaei S The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis Climacteric 2019 22 4 403 411 10.1080/13697137.2019.1574738 30829083
Golezar S, Ramezani Tehrani F, Khazaei S, et al. The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis. Climacteric. 2019;22(4):403–11.30829083 10.1080/13697137.2019.1574738
3. Subgroup M Chinese Society of Obstetrics and Gynecology, Chinese Medical Association Zhonghua Fu Chan Ke Za Zhi 2023 58 10 721 728 37849252
Subgroup M. Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Zhonghua Fu Chan Ke Za Zhi. 2023;58(10):721–8.37849252
4. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel The 2022 Hormone Therapy Position Statement of The North American Menopause Society Menopause 2022 29 7 767 794 10.1097/GME.0000000000002028 35797481
“The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022;29(7):767–94.35797481 10.1097/GME.0000000000002028
5. Roeters van Lennep JE Heida KY Bots ML Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis Eur J Prev Cardiol 2016 23 2 178 186 10.1177/2047487314556004 25331207
Roeters van Lennep JE, Heida KY, Bots ML, et al. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23(2):178–86.25331207 10.1177/2047487314556004
6. Lang RM Badano LP Mor-Avi V Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging J Am Soc Echocardiogr 2015 28 1 1 39e14 10.1016/j.echo.2014.10.003 25559473
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39e14.25559473 10.1016/j.echo.2014.10.003
7. Nagueh SF Smiseth OA Appleton CP Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging J Am Soc Echocardiogr 2016 29 4 277 314 10.1016/j.echo.2016.01.011 27037982
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314.27037982 10.1016/j.echo.2016.01.011
8. Tsiligiannis S Panay N Stevenson JC Premature ovarian insufficiency and long-term health consequences Curr Vasc Pharmacol 2019 17 6 604 609 10.2174/1570161117666190122101611 30819073
Tsiligiannis S, Panay N, Stevenson JC. Premature ovarian insufficiency and long-term health consequences. Curr Vasc Pharmacol. 2019;17(6):604–9.30819073 10.2174/1570161117666190122101611
9. Stevenson JC Collins P Hamoda H Cardiometabolic health in premature ovarian insufficiency Climacteric 2021 24 5 474 480 10.1080/13697137.2021.1910232 34169795
Stevenson JC, Collins P, Hamoda H, et al. Cardiometabolic health in premature ovarian insufficiency. Climacteric. 2021;24(5):474–80.34169795 10.1080/13697137.2021.1910232
10. Zhu D Chung HF Dobson AJ Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data Lancet Public Health 2019 4 11 e553 e564 10.1016/S2468-2667(19)30155-0 31588031
Zhu D, Chung HF, Dobson AJ, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553–64.31588031 10.1016/S2468-2667(19)30155-0
11. Ebong IA Watson KE Goff DC Jr Age at menopause and incident heart failure: the multi-ethnic study of atherosclerosis Menopause 2014 21 6 585 591 10.1097/GME.0000000000000138 24423934
Ebong IA, Watson KE, Goff DC Jr, et al. Age at menopause and incident heart failure: the multi-ethnic study of atherosclerosis. Menopause. 2014;21(6):585–91.24423934 10.1097/GME.0000000000000138
12. Esposito R Santoro C Sorrentino R Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: a speckle tracking echocardiography analysis Echocardiography 2019 36 7 1273 1281 10.1111/echo.14399 31246327
Esposito R, Santoro C, Sorrentino R, et al. Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: a speckle tracking echocardiography analysis. Echocardiography. 2019;36(7):1273–81.31246327 10.1111/echo.14399
13 Sharma S Lassen MCH Nielsen AB The clinical application of longitudinal layer specific strain as a diagnostic and prognostic instrument in ischemic heart diseases: a systematic review and meta-analysis Front Cardiovasc Med. 2023 10 980626 10.3389/fcvm.2023.980626 37051064
Sharma S, Lassen MCH, Nielsen AB, et al. The clinical application of longitudinal layer specific strain as a diagnostic and prognostic instrument in ischemic heart diseases: a systematic review and meta-analysis. Front Cardiovasc Med. 2023;10:980626.37051064 10.3389/fcvm.2023.980626
14. Shi J Pan C Kong D Left ventricular longitudinal and circumferential layer-specific myocardial strains and their determinants in healthy subjects Echocardiography 2016 33 4 510 518 10.1111/echo.13132 26661049
Shi J, Pan C, Kong D, et al. Left ventricular longitudinal and circumferential layer-specific myocardial strains and their determinants in healthy subjects. Echocardiography. 2016;33(4):510–8.26661049 10.1111/echo.13132
15. Shiino K Yamada A Scalia GM Early changes of myocardial function after transcatheter aortic valve implantation using multilayer strain speckle tracking echocardiography Am J Cardiol 2019 123 6 956 960 10.1016/j.amjcard.2018.12.008 30594290
Shiino K, Yamada A, Scalia GM, et al. Early changes of myocardial function after transcatheter aortic valve implantation using multilayer strain speckle tracking echocardiography. Am J Cardiol. 2019;123(6):956–60.30594290 10.1016/j.amjcard.2018.12.008
16. Skaarup KG Iversen A Jørgensen PG Association between layer-specific global longitudinal strain and adverse outcomes following acute coronary syndrome Eur Heart J Cardiovasc Imaging 2018 19 12 1334 1342 10.1093/ehjci/jey004 29617974
Skaarup KG, Iversen A, Jørgensen PG, et al. Association between layer-specific global longitudinal strain and adverse outcomes following acute coronary syndrome. Eur Heart J Cardiovasc Imaging. 2018;19(12):1334–42.29617974 10.1093/ehjci/jey004
17. Haynes MP Sinha D Russell KS Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells Circ Res 2000 87 8 677 682 10.1161/01.RES.87.8.677 11029403
Haynes MP, Sinha D, Russell KS, et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res. 2000;87(8):677–82.11029403 10.1161/01.RES.87.8.677
18. Li S Gupte AA The role of estrogen in cardiac metabolism and diastolic function Methodist Debakey Cardiovasc J 2017 13 1 4 8 10.14797/mdcj-13-1-4 28413575
Li S, Gupte AA. The role of estrogen in cardiac metabolism and diastolic function. Methodist Debakey Cardiovasc J. 2017;13(1):4–8.28413575 10.14797/mdcj-13-1-4
19. Ribeiro RF Jr Pavan BM Potratz FF Myocardial contractile dysfunction induced by ovariectomy requires AT1 receptor activation in female rats Cell Physiol Biochem 2012 30 1 1 12 10.1159/000339041 22759951
Ribeiro RF Jr, Pavan BM, Potratz FF, et al. Myocardial contractile dysfunction induced by ovariectomy requires AT1 receptor activation in female rats. Cell Physiol Biochem. 2012;30(1):1–12.22759951 10.1159/000339041
20. Aksoy MN Akdemir N Kilic H Pulse wave velocity and myocardial performance index in premature ovarian insufficiency Scand Cardiovasc J 2017 51 2 95 98 10.1080/14017431.2017.1285044 28098488
Aksoy MN, Akdemir N, Kilic H, et al. Pulse wave velocity and myocardial performance index in premature ovarian insufficiency. Scand Cardiovasc J. 2017;51(2):95–8.28098488 10.1080/14017431.2017.1285044
21. Wang H Sun X Ahmad S Estrogen modulates the differential expression of cardiac myocyte chymase isoforms and diastolic function Mol Cell Biochem 2019 456 1–2 85 93 10.1007/s11010-018-03492-6 30712071
Wang H, Sun X, Ahmad S, et al. Estrogen modulates the differential expression of cardiac myocyte chymase isoforms and diastolic function. Mol Cell Biochem. 2019;456(1–2):85–93.30712071 10.1007/s11010-018-03492-6
22. Machuki JO Zhang HY Geng J Estrogen regulation of cardiac cAMP-L-type Ca2+ channel pathway modulates sex differences in basal contraction and responses to β2AR-mediated stress in left ventricular apical myocytes Cell Commun Signal 2019 17 1 34 10.1186/s12964-019-0346-2 30987657
Machuki JO, Zhang HY, Geng J, et al. Estrogen regulation of cardiac cAMP-L-type Ca2+ channel pathway modulates sex differences in basal contraction and responses to β2AR-mediated stress in left ventricular apical myocytes. Cell Commun Signal. 2019;17(1):34.30987657 10.1186/s12964-019-0346-2
23. Gorodeski GI Update on cardiovascular disease in post-menopausal women Best Pract Res Clin Obstet Gynaecol 2002 16 3 329 355 10.1053/beog.2002.0282 12099666
Gorodeski GI. Update on cardiovascular disease in post-menopausal women. Best Pract Res Clin Obstet Gynaecol. 2002;16(3):329–55.12099666 10.1053/beog.2002.0282
24. Losordo DW Kearney M Kim EA Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women Circulation 1994 89 4 1501 1510 10.1161/01.CIR.89.4.1501 8149515
Losordo DW, Kearney M, Kim EA, et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994;89(4):1501–10.8149515 10.1161/01.CIR.89.4.1501
25. Cheng SB Graeber CT Quinn JA Filardo EJ Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus Steroids 2011 76 9 892 896 21354433
Cheng SB, Graeber CT, Quinn JA, Filardo EJ. Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus. Steroids. 2011;76(9):892–6.21354433
26. Huttin O Girerd N Coiro S Association between layer-specific longitudinal strain and risk factors of heart failure and dyspnea: a population-based study J Am Soc Echocardiogr 2019 32 7 854 865.e8 10.1016/j.echo.2019.03.011 31104890
Huttin O, Girerd N, Coiro S, et al. Association between layer-specific longitudinal strain and risk factors of heart failure and dyspnea: a population-based study. J Am Soc Echocardiogr. 2019;32(7):854-865.e8.31104890 10.1016/j.echo.2019.03.011
